BALTIMORE, Sept. 30 /PRNewswire/ -- CSA Medical, Inc. announced today the promotion of Steven E. Schaefer to President of CSA Medical, Inc. Steve Schaefer, Chief Financial Officer since November 2006, has been appointed President of CSA Medical, Inc. The Company, headquartered in Baltimore, Maryland, is the world's exclusive provider of a ground-breaking, therapeutic medical device. The device allows physicians to use endoscopes to quickly and easily spray supercool (-196 degrees C) liquid nitrogen onto unwanted tissues deep inside the body. Mr. Schaefer's additional responsibilities for the growth and operations of the company will allow company CEO and Board Chairman Tim Askew to expand the patented platform technology into additional treatment areas. "Steve will focus his efforts on expanding the early success of the GI business of CSA Medical," said Askew. He continued, "Over the past two years he has demonstrated a great capacity to drive visionary growth and has my confidence in taking the business to the next level."
CSA Medical has seen impressive growth since commercially launching the CryoSpray product in May 2007. During this time Mr. Schaefer has worked closely with VP of Sales and Marketing, Ric Hughen, to launch and expand sales of CSA Medical's device. In the first year of commercial availability the FDA-cleared technology has been adopted nationwide in over fifty top healthcare institutions and the pace of adoption is continuing to accelerate. "I am committed to drive CSA Medical and its fight against GI diseases to new levels while growing and protecting the remarkable culture of our organization," said Mr. Schaefer.
Steve Schaefer joined CSA Medical, Inc. with a background in finance, marketing, business development and sales leadership. A Certified Public Accountant, and Drexel University graduate, Steve previously has served in executive roles at several high-growth technology companies including RewardsPlus and FiberTech Medical.
About CSA Medical: CSA Medical, Inc is the manufacturer of the CryoSpray Ablation(TM) System. The CSA System utilizes a patented spray cryogenic technology that allows a physician to safely and effectively destroy a wide range of unwanted tissues via an endoscope.
For more information, please contact Richard Hughen at email@example.com.
|SOURCE CSA Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved